1. To improve benign essential blepharospasm in adults aged 18 and above.
2. To reduce the appearance of moderate to severe glabellar lines associated with corrugator muscle and/or
procerus muscle activity in adults aged 18 to 65.
3. To treat upper limb spasticity associated with stroke in adults aged 20 and above.
4. Treatment of dynamic equinus foot deformity in pediatric patients aged 2 and above with cerebral palsy.
5. To improve moderate to severe lateral canthal lines (crow’s feet lines) associated with orbicularis oculi muscle
activity in adults aged 19 to 65.
Shelf Life3 years in freeze-drying conditionsStorageStore at temperature of +2 to +8 °C